Efficacy and Tolerability Study to Treat Mild and Moderate Anxiety

Summary

To evaluate the efficacy and tolerability of the combination use of Passiflora incarnata L, Crataegus oxyacantha and Salix alba L in mild and moderate anxiety. Clinical study phase III, multicenter, prospective, open. Patients will be included in sufficient quantity to achieve the minimum number of 124 evaluable patients.

Timeline

Start

2009-09

Primary completion

2009-12

Completion

2010-01

Drugs

Indications